Dr. Hanjong Ahn is a urologic oncology surgeon who specializes in treating prostate cancer and urothelial cancer. He has expertise in robotic surgery and has completed more than 4,200 robotic prostatectomies for prostate cancer. He dedicated himself to the initiation and establishment of East Asia Urologic Oncology Society. His research is focused on mechanisms of drug resistance in the treatment of prostate cancer and the application of new drugs or methods to overcome the treatment resistance.
14th August 2025
Time |
Session |
|
09:00
15:00
|
-
Welcome Remarks
-
Welcome Remarks
-
Bladder Cancer Track
-
MDT Discussion: Treating High-Risk BCG Refractory NMIBC in a ECOG2 75-year-old
-
Debate: Bladder Preservation Should Be Considered for All Cases of MIBC
-
Technical Pearls: Node Dissection in Robotic Cystectomy
-
Technical Pearls: Robotic Intra-Corporeal OBS
-
Practice Changing Papers
-
Coffee Break
-
Prostate Cancer Track
-
MDT Discussion: Personalizing Treatment in High Volume CSPC
-
Debate: PIRADS 4/5 Negative Biopsies Should
-
Technical Pearls: Retzius Sparing
-
Technical Pearls: Nerve-Sparing
-
Technical Pearls: Total Extraperitoneal Technique
-
Practice Changing Papers
-
Group Photo
-
Lunch Break
-
Kidney Cancer Track
-
Treating SRM in a 65-Year-Old ECOG 1 with Multiple Previous Operations-Is Minimally Invasive Treatment Feasible?
-
Treating SRM in a 65-Year-Old ECOG 1 with Multiple Previous Operations-Is SBRT the New Kid on the Block?
-
Debate: Should We Only Offer Consolidative Cytoreductive Nephrectomy in Metastatic RCC?
-
Technical Pearls: Wheel-Barrow Techniques
-
Technical Pearls: Renorrhaphy Techniques
-
Practice Changing Papers
-
Closing Remarks
TICC - 1F 101A
|